Prot# CXA30007: A Phs III,12-Wk,Mltcntr,Dbl-Blind,Dbl-Dummy,Randomised,Placebo-&Active Comparator-Controlled,Parallel Group Study to Investigate the Efficacy&Safety of GW406381 1mg,5mg,10mg,25mg&50mg Admin Orally 1x Daily,in Adults w/Osteoar

Project: Research project

Project Details

StatusFinished
Effective start/end date8/8/0510/30/06

Funding

  • GlaxoSmithKline plc (CXA30007)